Invention:
This invention involves using magnetic resonance spectroscopy (MRS) to identify lipid-laden foam cells to diagnose a chronic stroke injury. This technology is specifically meant for monitoring patients post-stroke brain injury. This largely relates to improving management patient care and advancing stroke therapeutics.
Background:
Currently, MRS is a technology that is rarely applied to the diagnosis of chronic stroke injury. Additionally, current standards of care focus on an acute-phase assessment, rather than looking at the brain’s condition during the chronic phase and recovery. Utilizing MRS to identify lipid-laden foam cells during patient recovery will aid in diagnosis of stroke injuries and advance research in stroke therapeutics.
Applications:
- Stroke diagnostic
- Magnetic resonance spectroscopy (MRS)
- Lipid-laden foam cell identification
- Stroke recovery treatment
Advantages:
- Valuable diagnostic tool
- Advancement of stroke recovery treatments
- Better management of patient care
- Advances research
- Testing of new therapies
- More informed patient monitoring
